239 related articles for article (PubMed ID: 12402619)
1. Effects of human recombinant erythropoietin on inflammatory status in peritoneal dialysis patients.
Aguilera A; Bajo MA; Díez JJ; Ruiz-Caravaca ML; Vicenta Cuesta M; Alvarez V; Codoceo R; Selgas R
Adv Perit Dial; 2002; 18():200-5. PubMed ID: 12402619
[TBL] [Abstract][Full Text] [Related]
2. Malnutrition-inflammation syndrome is associated with endothelial dysfunction in peritoneal dialysis patients.
Aguilera A; Sánchez-Tomero JA; Bajo MA; Ruiz-Caravaca ML; Alvarez V; del Peso G; Herranz A; Cuesta MV; Castro MJ; Selgas R
Adv Perit Dial; 2003; 19():240-5. PubMed ID: 14763071
[TBL] [Abstract][Full Text] [Related]
3. Leptin as a marker of nutrition and cardiovascular risk in peritoneal dialysis patients.
Aguilera A; Bajo MA; Rebollo F; Díez JJ; Díaz C; Paiva A; Codoceo R; Selgas R
Adv Perit Dial; 2002; 18():212-7. PubMed ID: 12402621
[TBL] [Abstract][Full Text] [Related]
4. The relationships between activation of non-specific inflammatory process and malnutrition in patients on peritoneal dialysis.
Wójcik K; Stompór T; Krzanowski M; Miarka P; Zdzienicka A; Sułowicz W
Med Pregl; 2007; 60 Suppl 2():114-6. PubMed ID: 18928174
[TBL] [Abstract][Full Text] [Related]
5. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis.
Stompór T; Pasowicz M; Sulłowicz W; Dembińska-Kieć A; Janda K; Wójcik K; Tracz W; Zdzienicka A; Klimeczek P; Janusz-Grzybowska E
Am J Kidney Dis; 2003 Jan; 41(1):203-11. PubMed ID: 12500238
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
7. Hyperleptinaemia and chronic inflammation after peritonitis predicts poor nutritional status and mortality in patients on peritoneal dialysis.
Lam MF; Leung JC; Lo WK; Tam S; Chong MC; Lui SL; Tse KC; Chan TM; Lai KN
Nephrol Dial Transplant; 2007 May; 22(5):1445-50. PubMed ID: 17277343
[TBL] [Abstract][Full Text] [Related]
8. Serum level of vascular endothelial growth factor is influenced by erythropoietin treatment in peritoneal dialysis patients. (Grupo de Estudios Peritoneales de Madrid).
del Peso G; Selgas R; Bajo MA; Fernández de Castro M; Aguilera A; Cirugeda A; Jiménez C
Adv Perit Dial; 2000; 16():85-9. PubMed ID: 11045267
[TBL] [Abstract][Full Text] [Related]
9. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
10. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
[TBL] [Abstract][Full Text] [Related]
11. Adipocytokines leptin and adiponectin, and measures of malnutrition-inflammation in chronic renal failure: is there a relationship?
Dervisoglu E; Eraldemir C; Kalender B; Kir HM; Caglayan C
J Ren Nutr; 2008 Jul; 18(4):332-7. PubMed ID: 18558297
[TBL] [Abstract][Full Text] [Related]
12. Nutritional and inflammatory status of hemodialysis patients in relation to their body mass index.
Beberashvili I; Sinuani I; Azar A; Yasur H; Feldman L; Efrati S; Averbukh Z; Weissgarten J
J Ren Nutr; 2009 May; 19(3):238-47. PubMed ID: 19243974
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha as a uremic toxin: correlation with neuropathy, left ventricular hypertrophy, anemia, and hypertriglyceridemia in peritoneal dialysis patients.
Espinoza M; Aguilera A; Auxiliadora Bajo M; Codoceo R; Caravaca E; Cirugeda A; del Peso G; Hevia C; Selgas R
Adv Perit Dial; 1999; 15():82-6. PubMed ID: 10682077
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
16. Factors contributing to higher hematocrit levels in hemodialysis patients not receiving recombinant human erythropoietin.
Takeda A; Toda T; Shinohara S; Mogi Y; Matsui N
Am J Kidney Dis; 2002 Jul; 40(1):104-9. PubMed ID: 12087567
[TBL] [Abstract][Full Text] [Related]
17. Inflammation, peritoneal transport, and response to erythropoietin in peritoneal dialysis patients.
Pilkey RM; Morton AR; Iliescu EA
Adv Perit Dial; 2001; 17():153-7. PubMed ID: 11510266
[TBL] [Abstract][Full Text] [Related]
18. Additional effect of hyperparathyroidism on inflammatory status and rHuEPO requirements in hemodialysis patients.
Tutal E; Sezer S; Afsar B; Arat Z; Ozdemir FN; Haberal M
Transplant Proc; 2006 Nov; 38(9):2807-12. PubMed ID: 17112835
[TBL] [Abstract][Full Text] [Related]
19. Relationship between residual renal function, inflammation, and anemia in peritoneal dialysis.
Pérez-Flores I; Coronel F; Cigarrán S; Herrero JA; Calvo N
Adv Perit Dial; 2007; 23():140-3. PubMed ID: 17886621
[TBL] [Abstract][Full Text] [Related]
20. The role of serum leptin and tumor necrosis factor-alpha in malnutrition of male chronic obstructive pulmonary disease patients.
Yang YM; Sun TY; Liu XM
Chin Med J (Engl); 2006 Apr; 119(8):628-33. PubMed ID: 16635406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
